Insider · CIK 0002062209
Thomas D. Salus
officer
Files at LFCR (LIFECORE BIOMEDICAL, INC. \DE\). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | LFCR LIFECORE BIOMEDICAL, INC. \DE\ | AGrant or award Common Stock | +30,000 | - | - | 270,978 | Mar 2, 2026 |
| Jul 8, 2025 | LFCR LIFECORE BIOMEDICAL, INC. \DE\ | MOption exercise Common Stock | +37,000 | - | - | 252,000 | Jul 10, 2025 |
| Jul 8, 2025 | LFCR LIFECORE BIOMEDICAL, INC. \DE\ | FTax withholding Common Stock | -11,022 | $8.19 | $90k | 240,978 | Jul 10, 2025 |
| Jul 8, 2025 | LFCR LIFECORE BIOMEDICAL, INC. \DE\ | MOption exercise Performance-Based Restricted Stock Unitsderivative | -37,000 | - | - | 333,000 | Jul 10, 2025 |
| Apr 14, 2025 | LFCR LIFECORE BIOMEDICAL, INC. \DE\ | AGrant or award Common Stock | +45,000 | - | - | 45,000 | Apr 16, 2025 |
| Apr 14, 2025 | LFCR LIFECORE BIOMEDICAL, INC. \DE\ | AGrant or award Common Stock | +170,000 | - | - | 215,000 | Apr 16, 2025 |
| Apr 14, 2025 | LFCR LIFECORE BIOMEDICAL, INC. \DE\ | AGrant or award Performance-Based Restricted Stock Unitsderivative | +370,000 | $0.00 | $0 | 0 | Apr 16, 2025 |
| Apr 14, 2025 | LFCR LIFECORE BIOMEDICAL, INC. \DE\ | AGrant or award Incentive Stock Option (Right to Buy)derivative | +210,000 | $0.00 | $0 | 210,000 | Apr 16, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.